CLYM vs. ACM

Last updated Apr 1, 2026

Compare and contrast key facts about Climb Bio Inc (CLYM) and AECOM (ACM).

Performance

CLYM vs. ACM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Climb Bio Inc (CLYM) and AECOM (ACM). The values are adjusted to include any dividend payments, if applicable.

CLYM vs. ACM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CLYM Climb Bio Inc	71.25%	122.22%	-33.33%	-26.43%	-64.91%	-34.21%
ACM AECOM	-10.75%	-9.91%	16.67%	9.77%	10.72%	24.06%

Fundamentals

Market Cap CLYM : $461.48M ACM : $11.19B
EPS CLYM : -$0.88 ACM : $4.17
PB Ratio CLYM : 2.88 ACM : 5.02
Total Revenue (TTM) CLYM : $0.00 ACM : $15.96B
Gross Profit (TTM) CLYM : -$68.00K ACM : $1.23B
EBITDA (TTM) CLYM : -$63.77M ACM : $1.19B

Returns By Period

In the year-to-date period, CLYM achieves a 71.25% return, which is significantly higher than ACM's -10.75% return.

CLYM

• 1D: 4.74%
• 1M: -4.20%
• YTD: 71.25%
• 6M: 240.80%
• 1Y: 461.48%
• 3Y*: 33.18%
• 5Y*: —
• 10Y*: —

ACM

• 1D: 1.93%
• 1M: -13.43%
• YTD: -10.75%
• 6M: -34.66%
• 1Y: -7.60%
• 3Y*: 1.16%
• 5Y*: 6.50%
• 10Y*: 11.09%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CLYM vs. ACM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLYM

CLYM Risk / Return Rank: 98
CLYM Sharpe Ratio Rank: 99
CLYM Sortino Ratio Rank: 97
CLYM Omega Ratio Rank: 94
CLYM Calmar Ratio Rank: 99
CLYM Martin Ratio Rank: 99

ACM

ACM Risk / Return Rank: 31
ACM Sharpe Ratio Rank: 31
ACM Sortino Ratio Rank: 27
ACM Omega Ratio Rank: 27
ACM Calmar Ratio Rank: 37
ACM Martin Ratio Rank: 36

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLYM vs. ACM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Climb Bio Inc (CLYM) and AECOM (ACM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CLYM	ACM	Difference
Sharpe ratio Return per unit of total volatility	4.73	-0.25	+4.98
Sortino ratio Return per unit of downside risk	4.20	-0.13	+4.33
Omega ratio Gain probability vs. loss probability	1.47	0.98	+0.49
Calmar ratio Return relative to maximum drawdown	12.85	-0.20	+13.04
Martin ratio Return relative to average drawdown	32.85	-0.44	+33.29
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CLYM vs. ACM - Sharpe Ratio Comparison

The current CLYM Sharpe Ratio is 4.73, which is higher than the ACM Sharpe Ratio of -0.25. The chart below compares the historical Sharpe Ratios of CLYM and ACM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CLYM	ACM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	4.73	-0.25	+4.98
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.25	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.36	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.15	0.22	-0.37

Correlation

The correlation between CLYM and ACM is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CLYM vs. ACM - Dividend Comparison

CLYM has not paid dividends to shareholders, while ACM's dividend yield for the trailing twelve months is around 1.29%.

	TTM	2025	2024	2023	2022
CLYM Climb Bio Inc	0.00%	0.00%	0.00%	0.00%	0.00%
ACM AECOM	1.29%	1.09%	0.82%	0.78%	0.71%

Drawdowns

CLYM vs. ACM - Drawdown Comparison

The maximum CLYM drawdown since its inception was -96.05%, which is greater than ACM's maximum drawdown of -59.97%. Use the drawdown chart below to compare losses from any high point for CLYM and ACM.

Drawdown Indicators

	CLYM	ACM	Difference
Max Drawdown Largest peak-to-trough decline	-96.05%	-59.97%	-36.08%
Max Drawdown (1Y) Largest decline over 1 year	-33.87%	-37.87%	+4.00%
Max Drawdown (5Y) Largest decline over 5 years	—	-37.87%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-54.12%	—
Current Drawdown Current decline from peak	-76.06%	-36.67%	-39.39%
Average Drawdown Average peak-to-trough decline	-82.41%	-18.24%	-64.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.25%	16.90%	-3.65%

Volatility

CLYM vs. ACM - Volatility Comparison

Climb Bio Inc (CLYM) has a higher volatility of 19.45% compared to AECOM (ACM) at 6.88%. This indicates that CLYM's price experiences larger fluctuations and is considered to be riskier than ACM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CLYM	ACM	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.45%	6.88%	+12.57%
Volatility (6M) Calculated over the trailing 6-month period	77.48%	25.64%	+51.84%
Volatility (1Y) Calculated over the trailing 1-year period	98.47%	30.54%	+67.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	109.63%	25.85%	+83.78%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	109.63%	30.87%	+78.76%

Financials